![Xeris Pharmaceuticals erhält von der Europäischen Kommission die Zulassung für die Ogluo™-Injektion (Glucagon) zur Behandlung von schwerer Hypoglykämie bei Erwachsenen, Jugendlichen und Kindern ab 2 Jahren mit Diabetes mellitus | Business Wire Xeris Pharmaceuticals erhält von der Europäischen Kommission die Zulassung für die Ogluo™-Injektion (Glucagon) zur Behandlung von schwerer Hypoglykämie bei Erwachsenen, Jugendlichen und Kindern ab 2 Jahren mit Diabetes mellitus | Business Wire](https://mms.businesswire.com/media/20210213005019/de/858901/22/Ogluo_Blue_Pen.jpg)
Xeris Pharmaceuticals erhält von der Europäischen Kommission die Zulassung für die Ogluo™-Injektion (Glucagon) zur Behandlung von schwerer Hypoglykämie bei Erwachsenen, Jugendlichen und Kindern ab 2 Jahren mit Diabetes mellitus | Business Wire
![New diabetes treatment could eliminate need for insulin injections | Medical research | The Guardian New diabetes treatment could eliminate need for insulin injections | Medical research | The Guardian](https://i.guim.co.uk/img/media/16905b4faf21751c4e5af9a47ec1a58ca4fc8f4e/0_83_5200_3120/master/5200.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=c96832c7dd2955db2f838745ac8bc2f3)
New diabetes treatment could eliminate need for insulin injections | Medical research | The Guardian
![This New Treatment Could Provide Weeks of Glucose Control For Type 2 Diabetes Patients : ScienceAlert This New Treatment Could Provide Weeks of Glucose Control For Type 2 Diabetes Patients : ScienceAlert](https://www.sciencealert.com/images/articles/processed/diabetes-injection-glp1-molecule-shutterstock_600.jpg)
This New Treatment Could Provide Weeks of Glucose Control For Type 2 Diabetes Patients : ScienceAlert
![Ozempic: How a TikTok weight loss trend caused a global diabetes drug shortage - and health concerns | Euronews Ozempic: How a TikTok weight loss trend caused a global diabetes drug shortage - and health concerns | Euronews](https://static.euronews.com/articles/stories/07/27/54/86/1000x563_cmsv2_51f316f0-2412-5cfc-81f3-13a68a9b8b44-7275486.jpg)
Ozempic: How a TikTok weight loss trend caused a global diabetes drug shortage - and health concerns | Euronews
![Type 2 Diabetes Drug Tirzepatide (Mounjaro) Aids Weight Loss in People With Obesity: Study | Everyday Health Type 2 Diabetes Drug Tirzepatide (Mounjaro) Aids Weight Loss in People With Obesity: Study | Everyday Health](https://images.everydayhealth.com/images/mounjaro-weight-loss-study-alt-1440x810.png?sfvrsn=16c763ce_6)